Jenny Levy is a litigation partner who has practiced at Kirkland for over 27 years. She has appeared before trial courts and arbitration panels across the country. Jenny focuses on mass torts, complex commercial litigation, state Attorneys General litigation and investigations, class actions and MDLs, healthcare litigation and product liability work. She has litigated a wide variety of cases including consumer protection actions, public nuisance claims, allegations of commercial fraud and misrepresentation, data breaches, breaches of contract, business torts, antitrust and false claims qui tam actions. She is currently co-lead counsel on multiple high-profile multistate litigations brought by state Attorney Generals across the country and is a leading figure in similar large, complex litigation matters. Her practice has involved a diverse array of subject matters and allegations including Public Nuisance, Consumer Protection, Lending and Loan Servicing Practices, Medicaid/Medicare fraud, drug pricing fraud and unfair competition, contracts for the sale of energy, state and federal Fair Debt Collection Act (FDCA) violations, Telephone Consumer Protection Act (TCPA), collection contracts for the sale of businesses and stock purchase agreements, alleged violations of shareholder agreements, international licensing agreements, allegations of unlawful insurance practices, conspiracy and numerous product liability cases on behalf of manufacturers of automotive products, lead products, tobacco and pharmaceuticals. Jenny is a firm leader for pro bono work and has served as the pro bono coordinator for Kirkland’s Washington, D.C., office for twenty years.
Jenny’s representation of Baxter International was featured in “Lawyers: Hepatitis C outbreak doesn’t happen if drug makers sell smaller anesthetic vials,” from the September 12, 2011, Las Vegas Review-Journal.
Jenny is quoted in “Litigation Department of the Year,” The American Lawyer, January 2008, as a member of Kirkland’s winning Litigation Team for 2008.
Recognized by Benchmark Litigation as a Future Star from 2019–2023 and as a Litigation star in 2024
Recognized by Thomson Reuters as a Stand-Out Lawyer in 2023 and 2024
Recognized by Law360 as a Product Liability MVP in 2022
Recognized by The American Lawyer Litigation Daily as a “Litigator of the Week” in 2021
Recognized in The Legal 500 U.S. for Product Liability and Mass Tort Defense in both Pharmaceuticals and Medical Devices in 2012 and 2023, Consumer Products in 2012, 2013 and 2023 and Toxic Tort in 2022 and 2023
Recognized as one of the Minority Corporate Counsel Association’s (MCCA) Rainmakers in 2018
Profiled in The National Law Journal’s annual “Champions and Visionaries” feature in July 2012
Listed as a “Washington, D.C., Super Lawyer” by Super Lawyers magazine in 2013
Recognized as one of Fortune Magazine’s “Women Leaders in the Law” in 2013
Memberships & Affiliations
Admissions & Qualifications
- 1998New York
- 1999District of Columbia
- Duke University School of LawJ.D.cum laude1997
Special Projects Editor, Law and Contemporary Problems Law Journal
- Duke UniversityB.A.1994Dean’s List